Elevance Health Beats Q3 Profit Expectations Despite Rising Medical Costs
Elevance Health surpasses Wall Street Q3 profit estimates with $6.03 adjusted EPS, managing medical costs better than expected despite ongoing healthcare industry challenges.
Elevance Health surpasses Wall Street Q3 profit estimates with $6.03 adjusted EPS, managing medical costs better than expected despite ongoing healthcare industry challenges.
Centene's shares jumped! They confirmed profit goals, got good Medicare ratings, & saw better Medicaid costs. This signals a positive turnaround for the health insurer, easing investor worries.